Objective: This study presents the proportion of adults with intellectual disability using
psychotropic medications including antipsychotics, antidepressants, anxiolytics, hypnotics …

Introduction Australia's Royal Commission into Violence, Abuse, Neglect and Exploitation of
People with Disability (2019–2023) is examining, amongst many issues, how positive …

Background In a cohort of adults with intellectual disability who were followed for up to 16‐
years, we investigated characteristics associated with frequent emergency department (ED) …

As youth with intellectual and developmental disabilities (IDD) are transitioning from the
school systems and special education supports, many of them are moving into the adult …

This report presents the results of a survey completed by 973 people with involvement or
interest in Australian disability research. It is part of multi-phase research agenda setting …

The new Dutch Care and Coercion Act aims to better regulate the use of psychotropic drugs
for challenging behaviour in people with an intellectual disability. This study explores …

Background: Data on the health of adolescents with intellectual disability are scarce. This
study describes carer-reported symptoms, chronic illnesses, level of functioning, and …

Objectives: Psychotropic drugs are widely and often long-term used in intramural care for
people with intellectual disabilities and frail (often demented) elderly. This medication is …

In clinical practice of intellectual disability (ID) mental healthcare antipsychotics are
prescribed for a broad range of behavioral and mental problems. Prescriptions are often off …

Amaç: Entelektüel yetiyitimi gelişimsel süreçte ortaya çıkan, bireyin toplumsal, uygulamalı ve
kavramsal alanlarda işlevselliğini bozan nörogelişimsel bir bozukluktur. EY tanısı olan çocuk …